Breaking News Instant updates and real-time market news.

T

AT&T

$31.66

-0.56 (-1.74%)

, INCY

Incyte

$69.66

-1.49 (-2.09%)

10:11
07/13/18
07/13
10:11
07/13/18
10:11

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AT&T (T) downgraded to Market Perform from Outperform at Raymond James with analyst Frank Louthan saying he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. 2. Incyte (INCY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Matthew Harrison saying he believes key catalysts are unlikely until 2019 and he expects the stock to trade with the market in the meantime. 3. WisdomTree (WETF) was downgraded to Market Perform from Outperform at Keefe Bruyette and to Neutral from Buy at Citi. 4. Cedar Fair (FUN) downgraded to Neutral from Outperform at Macquarie. 5. Ingredion (INGR) downgraded to Sell from Neutral at Citi with analyst David Driscoll saying he expects the stock's valuation multiples to compress as investors sort through the number of issues that have come to light. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

T

AT&T

$31.66

-0.56 (-1.74%)

INCY

Incyte

$69.66

-1.49 (-2.09%)

WETF

WisdomTree

$9.00

-0.19 (-2.07%)

FUN

Cedar Fair

$59.47

0.58 (0.98%)

INGR

Ingredion

$100.05

-10.68 (-9.65%)

  • 24

    Jul

  • 27

    Jul

  • 31

    Jul

  • 01

    Aug

  • 02

    Aug

T AT&T
$31.66

-0.56 (-1.74%)

07/13/18
07/13/18
DOWNGRADE

Market Perform
AT&T downgraded to Market Perform following DOJ suit at Raymond James
As previously reported, Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan views the Department of Justice appeal of the Time Warner (TWX) case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail.
07/13/18
RAJA
07/13/18
DOWNGRADE
RAJA
Market Perform
AT&T downgraded to Market Perform from Outperform at Raymond James
07/13/18
MSCO
07/13/18
NO CHANGE
Target $37
MSCO
Overweight
Market likely to place low odds on AT&T deal reversal, says Morgan Stanley
After the DOJ decided to appeal District Court Judge Leon's order approving AT&T's merger with Time Warner, Morgan Stanley analyst Simon Flannery said he believes the market is likely to heavily rely on Judge Leon's "strongly worded decision" and assign a fairly low probability on a possible reversal of the deal. Even if AT&T were forced to divest assets, it would be into a fairly healthy market, added Flannery, who keeps an Overweight rating and $37 price target on the stock.
07/13/18
JEFF
07/13/18
NO CHANGE
Target $35
JEFF
Hold
DOJ faces 'uphill battle' in AT&T appeal, says Jefferies
While the Department of Justice's appeal of the AT&T-Time Warner case creates some uncertainty, the agency "faces an uphill battle," Jefferies analyst John Janedis tells investors in a research note. The analyst notes that Judge Leon was very clear in his ruling that he believed the government did not meet its burden of proof in the case, and discouraged the DOJ from asking for a stay. Janedis believes it could take a year or more before a final decision is made. He keeps a Hold rating on AT&T with a $35 price target.
INCY Incyte
$69.66

-1.49 (-2.09%)

07/13/18
MSCO
07/13/18
DOWNGRADE
MSCO
Equal Weight
Incyte downgraded to Equal Weight from Overweight at Morgan Stanley
07/13/18
MSCO
07/13/18
DOWNGRADE
Target $76
MSCO
Equal Weight
Incyte downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Incyte to Equal Weight from Overweight as he believes key catalysts are unlikely until 2019 and he expects the stock to trade with the market in the meantime. However, Harrison said he is positive on the depth and diversity of the company's pipeline following the analyst day deep-dive and he thinks 2019 could be a pivotal year. He maintains a $76 price target on Incyte shares.
06/26/18
06/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Underperform from Market Perform at Bernstein with analyst Stacy Rasgon saying she sees the CEO change and leadership vacuum providing some protection from further upward revisions, EPS growth slowing into 2019 as compares get harder and structural issues build, and an increasingly competitive environment. 2. LendingTree (TREE) downgraded to Neutral from Buy at Compass Point with analyst Michael Tarkan citing mortgage deceleration and remaining long-term cycle risks. 3. AMC Networks (AMCX) downgraded to Neutral from Buy at Goldman Sachs with analyst Drew Borst saying slowing advertising growth due to rating headwinds from The Walking Dead franchise and affiliate fee growth challenges in the pay TV ecosystem are a risk to earnings estimates. 4. Square (SQ) downgraded to Equal Weight from Overweight at Stephens with analyst Brett Huff stating that after a "truly remarkable" stock price acceleration over the past two years, he thinks Square is a "special" company, but is taking a breather. 5. Incyte (INCY) downgraded to Sector Perform from Outperform at RBC Capital with analyst Brian Abrahams noting that as he previously suggested, the market overreacted to the setbacks suffered by the company's epacadostat and baricitini programs when he also forecasted a rally to reflect the "substantial Jakafi growth opportunity through its out-year patent cliff". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/18
RBCM
06/26/18
DOWNGRADE
Target $74
RBCM
Sector Perform
Incyte downgraded to Sector Perform at RBC Capital on valuation
As reported earlier, RBC Capital analyst Brian Abrahams downgraded Incyte to Sector Perform from Outperform and lowered his price target to $74 from $76. The analyst notes that as he previously suggested, the market overreacted to the setbacks suffered by the company's epacadostat and baricitini programs when he also forecasted a rally to reflect the "substantial Jakafi growth opportunity through its out-year patent cliff". With the stock price up 23% from the bottom, Abrahams claims that his prediction has played out, keeping the stock price trading in line until greater visibility on new revenue opportunities emerges.
WETF WisdomTree
$9.00

-0.19 (-2.07%)

07/13/18
KBWI
07/13/18
DOWNGRADE
KBWI
Market Perform
WisdomTree downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee downgraded WisdomTree to Neutral and cut his price target to $10 from $12.50. Lee said WisdomTree's improving in organic growth was due to the dominance of the currency-hedged strategies, which should fade over time, and sees limited relative return potential.
05/16/18
DBAB
05/16/18
DOWNGRADE
Target $12
DBAB
Hold
WisdomTree downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded WisdomTree Investments (WETF) to Hold with an unchanged price target of $12. The analyst believes now is the time to get more bullish on active managers. The pace of passive manager share gains has "slowed dramatically" in 2018 given the sustained alpha generation in many active mutual fund categories versus comparable exchange traded funds, Bedell tells investors in a research note. The analyst coupled the downgrade of WisdomTree with an upgrade of T. Rowe Price (TROW) to Buy.
06/13/18
JEFF
06/13/18
NO CHANGE
Target $13
JEFF
Buy
WisdomTree a 'desirable asset' for asset managers, says Jefferies
After spending time with management, Jefferies analyst Daniel Fannon raised his price target for WisdomTree Investments to $13 from $12.50 and keeps a Buy rating on the shares. While the hedged products remain a headwind to near term flows, flows across the remaining portion of the complex look solid, Fannon tells investors in a research note. The analyst sees continued diversity of flows and successful integration of the ETFS transaction as near term opportunities for WisdomTree. Further, following recent deals in the space, Fannon calls the company a "unique and desirable asset for larger traditional asset managers."
07/13/18
SBSH
07/13/18
DOWNGRADE
SBSH
Neutral
WisdomTree downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded WisdomTree to Neutral from Buy ahead of Q2 earnings season for the broker and asset manager group in a note partially titled "Not Time For Hero Ball." The analyst, who introduced new estimates for the group, noted that he still prefers alternative managers.
FUN Cedar Fair
$59.47

0.58 (0.98%)

07/13/18
MACQ
07/13/18
DOWNGRADE
MACQ
Neutral
Cedar Fair downgraded to Neutral from Outperform at Macquarie
07/12/18
07/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Neutral from Buy at UBS with analyst Eric Sheridan saying the stock has appreciated 35% since the Q1 earnings report and 117% year-to-date. 2. Perrigo (PRGO) downgraded to Sell from Neutral at Goldman Sachs with analyst Jami Rubin saying she sees "no meaningful risk" to estimates but expects the "business to drift" due to a lack of meaningful new launches in the pipeline. 3. Extra Space Storage (EXR) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Andrew Rosivach citing significant share price outperformance and relative valuation. 4. Cedar Fair (FUN) downgraded to Neutral from Buy at Goldman Sachs with analyst Christopher Prykull citing the softer-than-expected mid-year revenue update. 5. Broadcom (AVGO) downgraded to In Line from Outperform at Evercore ISI, to Outperform from Top Pick at RBC Capital, to Neutral from Buy at B. Riley FBR, and to Neutral from Outperform at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/18
GSCO
07/12/18
DOWNGRADE
Target $63
GSCO
Neutral
Cedar Fair downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Christopher Prykull downgraded Cedar Fair to Neutral and lowered its price target to $63 from $79 following the softer-than-expected mid-year revenue update. Prykull said Cedar's fundamentals have disappointed relative to his initial expectations and have not benefited from the robust leisure spending backdrop.
02/15/18
HDLY
02/15/18
NO CHANGE
HDLY
Hilliard Lyons optimistic on Cedar Fair's prospects for 2018
Hilliard Lyons analyst Jeffrey Thomison called Cedar Fairs Q4 earnings results mixed, saying revenues were encouraging, but profit was disappointing. Thomison believes a combination of "effective capital spending at the parks, added hotel capacity, incremental sales opportunities, and relatively easy comparison to 2017" could produce considerably improved profits in 2018 that could please investors, and maintained a Long Term Buy and $77 price target on Cedar Fair shares.
INGR Ingredion
$100.05

-10.68 (-9.65%)

06/27/18
VERF
06/27/18
UPGRADE
VERF
Buy
Ingredion upgraded to Buy from Hold at Vertical Group
07/13/18
07/13/18
DOWNGRADE
Target $95

Sell
Ingredion downgraded to Sell after guidance cut at Citi
As previously reported, Citi analyst David Driscoll downgraded Ingredion to Sell from Neutral after the company lowered its Q2 and 2018 EPS forecast, stating that he expects the stock's valuation multiples to compress as investors sort through the number of issues that have come to light. He set a $95 price target on Ingredion shares.
07/13/18
SBSH
07/13/18
DOWNGRADE
SBSH
Sell
Ingredion downgraded to Sell from Neutral at Citi
07/13/18
07/13/18
NO CHANGE
Target $145

Buy
Ingredion long-term thesis remains intact, says Jefferies
Jefferies analyst Akshay Jagdale says the long-term thesis on Ingredion remains intact despite the company's "disappointing" Q2 preannouncement. HFCS is a fairly small portion of Ingredion's overall portfolio and been in secular decline for some time, Jagdale tells investors in a research note. The analyst's long-term thesis is predicated more on Specialty business growth, which he says remains on track. Further, he believes the newly announced cost savings program should accelerate margin expansion. Jagdale reiterates a Buy rating on Ingredion with a $145 price target.

TODAY'S FREE FLY STORIES

02:40
07/20/18
07/20
02:40
07/20/18
02:40
General news
FX Update: The Dollar has been trading with a softer bias »

FX Update: The Dollar has…

02:35
07/20/18
07/20
02:35
07/20/18
02:35
General news
China bourses in late rally after yuan devaluation »

China bourses in late…

01:50
07/20/18
07/20
01:50
07/20/18
01:50
General news
The PBoC devalued the Yuan »

The PBoC devalued the…

01:45
07/20/18
07/20
01:45
07/20/18
01:45
General news
Asian Market Outlook: »

Asian Market Outlook:…

23:55
07/19/18
07/19
23:55
07/19/18
23:55
General news
Japan's core CPI improved to a 0.8% pace in June »

Japan's core CPI…

YUMC

Yum China

$36.00

-0.8 (-2.17%)

20:46
07/19/18
07/19
20:46
07/19/18
20:46
Downgrade
Yum China rating change at BofA/Merrill »

Yum China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 10

    Sep

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

20:45
07/19/18
07/19
20:45
07/19/18
20:45
Downgrade
Mersana Therapeutics rating change at Leerink »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$13.73

-0.02 (-0.15%)

, HON

Honeywell

$147.57

-1.58 (-1.06%)

20:25
07/19/18
07/19
20:25
07/19/18
20:25
Earnings
Notable companies reporting before tomorrow's openGentex »

Notable companies…

GE

General Electric

$13.73

-0.02 (-0.15%)

HON

Honeywell

$147.57

-1.58 (-1.06%)

SLB

Schlumberger

$66.91

-0.16 (-0.24%)

BHGE

Baker Hughes

$31.75

-0.79 (-2.43%)

STT

State Street

$92.84

-2.505 (-2.63%)

VFC

VF Corp.

$89.21

1 (1.13%)

STI

SunTrust

$69.00

-0.85 (-1.22%)

SWK

Stanley Black & Decker

$139.60

1.33 (0.96%)

RF

Regions Financial

$17.62

-0.43 (-2.38%)

CFG

Citizens Financial

$40.66

-0.365 (-0.89%)

KSU

Kansas City Southern

$108.48

1.93 (1.81%)

GNTX

Gentex

$23.41

-0.41 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 08

    Aug

  • 19

    Oct

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

20:11
07/19/18
07/19
20:11
07/19/18
20:11
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Aug

  • 27

    Aug

CDNS

Cadence Design

$45.24

-0.29 (-0.64%)

20:04
07/19/18
07/19
20:04
07/19/18
20:04
Hot Stocks
Cadence Design announces Sigrity 2018 release »

Cadence Design announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

AVA

Avista

$50.40

0.06 (0.12%)

19:33
07/19/18
07/19
19:33
07/19/18
19:33
Hot Stocks
Idaho Public Utilities Commission postpones Avista and Hydro One merger hearing »

Hydro One Limited and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

CRK

Comstock Resources

$11.35

-0.2 (-1.73%)

19:28
07/19/18
07/19
19:28
07/19/18
19:28
Hot Stocks
Comstock Resources acquires Haynesville shale assets for $31M »

Comstock Resources, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

GRPN

Groupon

$4.76

0.04 (0.85%)

, IBM

IBM

$149.25

4.81 (3.33%)

19:16
07/19/18
07/19
19:16
07/19/18
19:16
Periodicals
Groupon lawyer says IBM shakes down other tech companies, Reuters says »

A lawyer for Groupon…

GRPN

Groupon

$4.76

0.04 (0.85%)

IBM

IBM

$149.25

4.81 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WDC

Western Digital

$77.45

-1.33 (-1.69%)

19:06
07/19/18
07/19
19:06
07/19/18
19:06
Hot Stocks
Western Digital begins sampling 1.33 terrabit 3D NAND »

Western Digital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CE

Celanese

$109.84

-1.17 (-1.05%)

, LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

CE

Celanese

$109.84

-1.17 (-1.05%)

LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

MSFT

Microsoft

$104.70

-0.38 (-0.36%)

SWKS

Skyworks

$102.46

0.41 (0.40%)

COF

Capital One

$95.32

-1.77 (-1.82%)

ETFC

E-Trade

$61.20

-1.94 (-3.07%)

PTCT

PTC Therapeutics

$36.61

1.59 (4.54%)

RWT

Redwood Trust

$16.64

0.135 (0.82%)

AEP

American Electric

$70.65

0.41 (0.58%)

WEC

WEC Energy

$65.23

0.51 (0.79%)

SKX

Skechers

$33.24

0.61 (1.87%)

FTD

FTD Companies

$4.52

0.06 (1.35%)

ZYNE

Zynerba

$10.40

0.24 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 27

    Aug

  • 04

    Sep

  • 20

    Jul

BG

Bunge

$67.99

-0.43 (-0.63%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Periodicals
Bunge in talks to sell part of sugar trading unit to Wilmar, Bloomberg says »

Bunge is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

PEG

PSEG

$52.18

0.42 (0.81%)

18:42
07/19/18
07/19
18:42
07/19/18
18:42
Downgrade
PSEG rating change at Goldman Sachs »

PSEG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$65.23

0.51 (0.79%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
WEC Energy rating change at Goldman Sachs »

WEC Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$70.65

0.41 (0.58%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
American Electric rating change at Goldman Sachs »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ETR

Entergy

$80.97

0.465 (0.58%)

18:40
07/19/18
07/19
18:40
07/19/18
18:40
Upgrade
Entergy rating change at Goldman Sachs »

Entergy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

, INCY

Incyte

$70.10

-0.3 (-0.43%)

18:33
07/19/18
07/19
18:33
07/19/18
18:33
Hot Stocks
Lancet study shows benefit of Baricitinib 4 mg for treatment of SLE »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

INCY

Incyte

$70.10

-0.3 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 10

    Sep

T

AT&T

$31.27

-0.46 (-1.45%)

18:20
07/19/18
07/19
18:20
07/19/18
18:20
Periodicals
U.S. court clears expedited appeal of AT&T-Time Warner deal, Reuters says »

A federal appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

VLKAY

Volkswagen

$0.00

(0.00%)

18:17
07/19/18
07/19
18:17
07/19/18
18:17
Periodicals
VW to furlough roughly 1,000 workers at biggest factory in Brazil, Reuters says »

Volkswagen intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

, GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

18:09
07/19/18
07/19
18:09
07/19/18
18:09
Periodicals
Google faces uphill but not insurmountable fight to appeal EU fine, WSJ says »

Google (GOOG) parent…

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

INTC

Intel

$52.01

0.3 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 18

    Sep

  • 28

    Oct

NWE

NorthWestern

$58.29

0.56 (0.97%)

18:03
07/19/18
07/19
18:03
07/19/18
18:03
Earnings
Breaking Earnings news story on NorthWestern »

NorthWestern reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.